These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37583821)

  • 21. Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein.
    Wang Y; Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2007 Nov; 282(46):33247-33251. PubMed ID: 17911111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and structure-activity relationship of aminoarylthiazole derivatives as correctors of the chloride transport defect in cystic fibrosis.
    Pesce E; Bellotti M; Liessi N; Guariento S; Damonte G; Cichero E; Galatini A; Salis A; Gianotti A; Pedemonte N; Zegarra-Moran O; Fossa P; Galietta LJ; Millo E
    Eur J Med Chem; 2015 Jun; 99():14-35. PubMed ID: 26041577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening.
    Pedemonte N; Lukacs GL; Du K; Caci E; Zegarra-Moran O; Galietta LJ; Verkman AS
    J Clin Invest; 2005 Sep; 115(9):2564-71. PubMed ID: 16127463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergy-based small-molecule screen using a human lung epithelial cell line yields ΔF508-CFTR correctors that augment VX-809 maximal efficacy.
    Phuan PW; Veit G; Tan J; Roldan A; Finkbeiner WE; Lukacs GL; Verkman AS
    Mol Pharmacol; 2014 Jul; 86(1):42-51. PubMed ID: 24737137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrector VX-809 promotes interactions between cytoplasmic loop one and the first nucleotide-binding domain of CFTR.
    Loo TW; Clarke DM
    Biochem Pharmacol; 2017 Jul; 136():24-31. PubMed ID: 28366727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenylglycine and sulfonamide correctors of defective delta F508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating.
    Pedemonte N; Sonawane ND; Taddei A; Hu J; Zegarra-Moran O; Suen YF; Robins LI; Dicus CW; Willenbring D; Nantz MH; Kurth MJ; Galietta LJ; Verkman AS
    Mol Pharmacol; 2005 May; 67(5):1797-807. PubMed ID: 15722457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenylhydrazones as Correctors of a Mutant Cystic Fibrosis Transmembrane Conductance Regulator.
    Nieddu E; Pollarolo B; Mazzei MT; Anzaldi M; Schenone S; Pedemonte N; Galietta LJ; Mazzei M
    Arch Pharm (Weinheim); 2016 Feb; 349(2):112-23. PubMed ID: 26701662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystic Fibrosis Transmembrane Conductance Regulator Folding Mutations Reveal Differences in Corrector Efficacy Linked to Increases in Immature Cystic Fibrosis Transmembrane Conductance Regulator Expression.
    Peters KW; Gong X; Frizzell RA
    Front Physiol; 2021; 12():695767. PubMed ID: 34764878
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.
    Ben Saad A; Vauthier V; Tóth Á; Janaszkiewicz A; Durand-Schneider AM; Bruneau A; Delaunay JL; Lapalus M; Mareux E; Garcin I; Gonzales E; Housset C; Aït-Slimane T; Jacquemin E; Di Meo F; Falguières T
    Liver Int; 2021 Jun; 41(6):1344-1357. PubMed ID: 33650203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compounds that correct F508del-CFTR trafficking can also correct other protein trafficking diseases: an in vitro study using cell lines.
    Sampson HM; Lam H; Chen PC; Zhang D; Mottillo C; Mirza M; Qasim K; Shrier A; Shyng SL; Hanrahan JW; Thomas DY
    Orphanet J Rare Dis; 2013 Jan; 8():11. PubMed ID: 23316740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel.
    Renda M; Barreca M; Borrelli A; Spanò V; Montalbano A; Raimondi MV; Bivacqua R; Musante I; Scudieri P; Guidone D; Buccirossi M; Genovese M; Venturini A; Bandiera T; Barraja P; Galietta LJV
    Sci Rep; 2023 May; 13(1):7604. PubMed ID: 37165082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased folding and channel activity of a rare cystic fibrosis mutant with CFTR modulators.
    Caldwell RA; Grove DE; Houck SA; Cyr DM
    Am J Physiol Lung Cell Mol Physiol; 2011 Sep; 301(3):L346-52. PubMed ID: 21642448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones.
    Wang Y; Bartlett MC; Loo TW; Clarke DM
    Mol Pharmacol; 2006 Jul; 70(1):297-302. PubMed ID: 16624886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of novel thiazole- VX-809 hybrid derivatives as F508del correctors by QSAR-based filtering tools.
    Liessi N; Cichero E; Pesce E; Arkel M; Salis A; Tomati V; Paccagnella M; Damonte G; Tasso B; Galietta LJV; Pedemonte N; Fossa P; Millo E
    Eur J Med Chem; 2018 Jan; 144():179-200. PubMed ID: 29272749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing the Potency of F508del Correction: A Multi-Layer Combinational Approach to Drug Discovery for Cystic Fibrosis.
    Kirby EF; Heard AS; Wang XR
    J Pharmacol Clin Toxicol; 2013 Aug; 1(1):1007. PubMed ID: 24855632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis.
    Sloane PA; Rowe SM
    Curr Opin Pulm Med; 2010 Nov; 16(6):591-7. PubMed ID: 20829696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capturing the Direct Binding of CFTR Correctors to CFTR by Using Click Chemistry.
    Sinha C; Zhang W; Moon CS; Actis M; Yarlagadda S; Arora K; Woodroofe K; Clancy JP; Lin S; Ziady AG; Frizzell R; Fujii N; Naren AP
    Chembiochem; 2015 Sep; 16(14):2017-22. PubMed ID: 26227551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The search for a common structural moiety among selected pharmacological correctors of the mutant CFTR chloride channel.
    Nieddu E; Pollarolo B; Mazzei MT; Anzaldi M; Schenone S; Pedemonte N; Pesce E; Galietta LJ; Mazzei M
    Future Med Chem; 2014; 6(17):1857-68. PubMed ID: 25495980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correcting CFTR folding defects by small-molecule correctors to cure cystic fibrosis.
    Mijnders M; Kleizen B; Braakman I
    Curr Opin Pharmacol; 2017 Jun; 34():83-90. PubMed ID: 29055231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correctors promote folding of the CFTR in the endoplasmic reticulum.
    Loo TW; Bartlett MC; Clarke DM
    Biochem J; 2008 Jul; 413(1):29-36. PubMed ID: 18361776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.